Trial intelligence / Profile preview

Labetalol versus hydralazine for severe hypertension in preeclampsia

IRCT201012185414N1Phase 3Completed

Sponsor
Kashan University of Medical Sciences
Start
Apr 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of labetalol and hydralazine in preeclampsia (2 arms), sponsored by Kashan University of Medical Sciences. Started Apr 2009; status: completed.

02

Drugs

labetalolhydralazine
03

Conditions

preeclampsia

Beyond the preview

Go deeper on IRCT201012185414N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201012185414N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call